IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 35 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,943,000 | +1.7% | 2,500,000 | 0.0% | 0.02% | +5.9% |
| Q4 2017 | $2,894,000 | -2.6% | 2,500,000 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $2,970,000 | -11.2% | 2,500,000 | 0.0% | 0.02% | -15.0% |
| Q2 2017 | $3,345,000 | +7.6% | 2,500,000 | 0.0% | 0.02% | +11.1% |
| Q1 2017 | $3,108,000 | +8.6% | 2,500,000 | 0.0% | 0.02% | +5.9% |
| Q4 2016 | $2,861,000 | +20.0% | 2,500,000 | +25.0% | 0.02% | +21.4% |
| Q3 2016 | $2,384,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,953,000 | 0.83% |
| CSS LLC/IL | 10,119,000 | $11,031,000 | 0.46% |
| DeepCurrents Investment Group LLC | 13,556,000 | $14,917,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $11,014,000 | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,592,000 | $31,218,000 | 0.24% |
| HBK INVESTMENTS L P | 14,616,000 | $15,971,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,334,000 | 0.05% |
| Verition Fund Management LLC | 3,942,000 | $4,304,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 10,037,000 | $10,959,000 | 0.01% |
| Calamos Advisors LLC | 2,423,000 | $2,648,000 | 0.01% |